Emily Pimblett - Mar 13, 2023 Form 3 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
Chief Accounting Officer
Signature
/s/ Brian Woodard, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Mar 13, 2023
Transactions value $
$0
Form type
3
Date filed
3/21/2023, 10:21 AM
Next filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ELYM Stock Option (Right to Buy) Mar 13, 2023 Common Stock 35K $6.10 Direct F1
holding ELYM Stock Option (Right to Buy) Mar 13, 2023 Common Stock 30K $8.21 Direct F2
holding ELYM Stock Option (Right to Buy) Mar 13, 2023 Common Stock 30K $3.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest at a rate of 12/48ths of the total number of shares on the one-year anniversary of March 26, 2021 (the "March 2021 Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the March 2021 Vesting Commencement Date thereafter for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the March 2021 Vesting Commencement Date.
F2 The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of January 27, 2022 (the "January 2022 Vesting Commencement Date") for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the January 2022 Vesting Commencement Date.
F3 The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "October 2022 Vesting Commencement Date") for so long as the Reporting Person remains an officer, director, employee, consultant and/or advisor of the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the October 2022 Vesting Commencement Date.